ERNA - Company ID 0000748592
Eterna Therapeutics Inc. (ERNA) reported revenue of $582.00K for fiscal year 2024, as filed in its audited annual report with the SEC.
| Fiscal year | Revenue | Change |
|---|---|---|
| FY 2024 | $582.00K | +755.9% |
| FY 2023 | $68.00K | - |
| FY 2022 | $0.00 | -100.0% |
| FY 2020 | $5.80M | -70.7% |
| FY 2019 | $19.81M | -15.1% |
| FY 2018 | $23.34M | +9.7% |
| FY 2017 | $21.27M | -4.7% |
| FY 2016 | $22.31M | -9.0% |
| FY 2015 |
Between fiscal 2010 and fiscal 2024, Eterna Therapeutics Inc.'s revenue declined from $25.31M to $582.00K.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $24.52M |
| -5.9% |
| FY 2014 | $26.05M | +9.7% |
| FY 2013 | $23.75M | -1.3% |
| FY 2012 | $24.06M | +0.8% |
| FY 2011 | $23.87M | -5.7% |
| FY 2010 | $25.31M | - |